O accumulating data to determine how to modify the design of ongoing trials according to a prespecified plan • intended to increase quality, speed, and efficiency of trials • typically involve interim analysis, changes to sample size, changes to in randomization to treatment arms and control groups and changes in dosage or regimen of drug or other technology